cefoperazone has been researched along with Mastitis, Bovine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Albuquerque, KRS; Diaz, MAN; Muñoz, GD; Píccolo, MS; Pizziolo, VR; Purgato, GA; Rodrigues, FF; Rossi, CC | 1 |
| Ansari, MN; Gautam, S; Kaithwas, G; Rawat, JK; Roy, S; Saeedan, AS; Singh, L; Singh, M; Yadav, RK | 1 |
| Burmańczuk, A; Błądek, T; Dębiak, P; Grabowski, T; Kowalski, C | 1 |
| Burmańczuk, A; Grabowski, T; Kowalski, C; Wojciechowska, B | 1 |
| Feßler, AT; Schwarz, S; Turnidge, J | 1 |
| Feßler, AT; Kaspar, H; Lindeman, CJ; Peters, T; Schwarz, S; Watts, JL | 1 |
| Kaithwas, G; Kumar, P; Majumdar, DK; Mukerjee, A | 1 |
| Cagnardi, P; Carli, S; Gallo, M; Locatelli, C; Moroni, P; Villa, R; Zonca, A | 1 |
| Fessler, AT; Kaspar, H; Lindeman, CJ; Mankertz, J; Peters, T; Schwarz, S; Stegemann, MR; Watts, JL | 1 |
| Anderson, JC; Craven, N | 1 |
| Agger, N; Gilbert, GA; Thomasson, CA; Tolling, ST; Wilson, CD | 1 |
| Gilbert, GA; Wilson, CD | 1 |
12 other study(ies) available for cefoperazone and Mastitis, Bovine
| Article | Year |
|---|---|
Formulations of essential oils obtained from plants traditionally used as condiments or traditional medicine active against Staphylococcus aureus isolated from dairy cows with mastitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Cefoperazone; Condiments; Female; Humans; Mastitis, Bovine; Medicine, Traditional; Microbial Sensitivity Tests; Oils, Volatile; Plants; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Short communication: Evaluation of α-linolenic acid-based intramammary nanosuspension for treatment of subclinical mastitis.
Topics: alpha-Linolenic Acid; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cattle; Cefoperazone; Cell Count; Female; Inflammation; Mammary Glands, Animal; Mastitis, Bovine; Milk; Nanotechnology | 2020 |
Withdrawal of cefoperazone with milk after intramammary administration in dairy cows - prospective and retrospective analysis.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cattle; Cefoperazone; Drug Administration Routes; Drug Residues; Female; Half-Life; Mastitis, Bovine; Milk; Retrospective Studies | 2017 |
Impact of milk yield on pharmacokinetics of six intramammary drugs - a population approach.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefoperazone; Female; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Milk; Pharmaceutical Preparations | 2018 |
Quality control ranges for cefoperazone 30 μg disks for Staphylococcus aureus ATCC® 25923 and Escherichia coli ATCC® 25922.
Topics: Animals; Cattle; Cefoperazone; Disk Diffusion Antimicrobial Tests; Escherichia coli; Female; Mastitis, Bovine; Quality Control; Staphylococcus aureus | 2014 |
Proposal for agar disk diffusion interpretive criteria for susceptibility testing of bovine mastitis pathogens using cefoperazone 30μg disks.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefoperazone; Disk Diffusion Antimicrobial Tests; Escherichia coli; Female; Mastitis, Bovine; Milk; Streptococcus | 2017 |
Linum usitatissimum (linseed/flaxseed) fixed oil: antimicrobial activity and efficacy in bovine mastitis.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Candida albicans; Cattle; Cefoperazone; Escherichia coli; Female; Flax; Linseed Oil; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Staphylococcus aureus; Streptococcus agalactiae | 2011 |
Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefoperazone; Chromatography, High Pressure Liquid; Drug Administration Routes; Female; Mammary Glands, Animal; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Staphylococcal Infections | 2010 |
A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefoperazone; Escherichia coli; Escherichia coli Infections; Female; Germany; Mastitis, Bovine; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus; United States | 2012 |
Assessment in the mouse of cefoperazone as a treatment for mastitis.
Topics: Animals; Bacterial Infections; Cattle; Cefoperazone; Cloxacillin; Disease Models, Animal; Female; Kinetics; Mammary Glands, Animal; Mastitis; Mastitis, Bovine; Mice; Pregnancy; Staphylococcal Infections; Staphylococcus | 1984 |
Field trials with cefoperazone in the treatment of bovine clinical mastitis.
Topics: Animals; Cattle; Cefoperazone; Denmark; Escherichia coli; Escherichia coli Infections; Female; France; Mastitis, Bovine; Milk; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Sweden; United Kingdom | 1986 |
Pharmacokinetics of cefoperazone in the cow by the intramammary route and its effect on mastitis pathogens in vitro.
Topics: Animals; Cattle; Cefoperazone; Drug Resistance, Microbial; Escherichia coli; Female; Kinetics; Mammary Glands, Animal; Mastitis, Bovine; Milk; Salmonella | 1986 |